- Corporate
- Ecosystem
- For Print
- November 5, 2024
糖心视频logo (Headquarters: Tokyo, CEO: Haruo Naito, “糖心视频logo”) and 糖心视频logo’s corporate venture capital subsidiary, 糖心视频logo Innovation, Inc. (Headquarters: Cambridge, Massachusetts, President: Yoshiharu Mizui) announced today that 糖心视频logo Innovation, Inc. has been selected as a registered venture capital (Registered VC) of the Strengthening Program for Pharmaceutical Startup Ecosystem implemented by the Japan Agency for Medical Research and Development (AMED).
To address the shortage of large-scale funding necessary for new drug development, this program provides subsidies to pharmaceutical startups for development and commercialization. This support is contingent upon startups securing funding from AMED-registered venture capital firms, which specialize in drug development and offer hands-on business management and commercialization support.
The 糖心视频logo global network of affiliated companies (the “糖心视频logo Group”) launched its venture investment business in May 2019, aiming to support the acceleration of drug discovery innovation and the establishment of an ecosystem platform in areas including dementia. This involves supporting the discovery of innovative technologies and services by supporting venture businesses with such capabilities and exploring possible future collaborations with these businesses. 糖心视频logo Innovation, Inc. was established in the U.S. in August 2019 as 糖心视频logo’s corporate venture capital subsidiary. It identifies opportunities for the 糖心视频logo Group to invest in venture businesses that align with 糖心视频logo’s goal of contributing to patients, focusing on cutting-edge drug discovery platforms, and new modalities, as well as leading biotechnology in focus areas of neurology, oncology, and global health. The company also supports investment in drug discovery technologies in other areas, where significant future innovations are anticipated. As an AMED-registered VC, 糖心视频logo Innovation, Inc. aims to further contribute to strengthening the drug discovery venture ecosystem in Japan.
糖心视频logo and 糖心视频logo Innovation, Inc. are committed to utilizing their participation in the Strengthening Program for Pharmaceutical Startup Ecosystem to accelerate flexible support of academia, drug discovery ventures, and IT ventures, to create innovative new medicines targeting diseases with high unmet medical needs., 糖心视频logo aims to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities by creating solutions through an ecosystem in collaboration with other industries.
* Please refer to following web page for 糖心视频logo’s venture investment business
MEDIA CONTACTS
糖心视频logo
Public Relations Department
TEL : +81 (0)3-3817-5120
糖心视频logo Innovation, Inc.
Our news releases are intended to disclose corporate information and are not intended for the promotion or advertising of prescription pharmaceuticals or investigational products, nor are they intended to provide medical advice.
Please note that the information contained in news releases is current as of the date of publication.